Veeva Systems Inc. Class A VEEV

Veeva Systems (NYSE: VEEV) today announced that Servier is standardizing customer reference data across more than 80 countries with Veeva OpenData. Building on its global success with Veeva Link Key People, a leading French pharmaceutical company governed by a Foundation, is harmonizing customer reference data and creating a unified foundation to scale AI.

Veeva Systems has underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.

In recent days, Veeva Systems has rolled out new AI-powered tools such as Veeva Study Builder Agent and Veeva Falcon Router, while announcing major customer wins including Oxford Biomedica adopting Veeva Quality Cloud and Amgen planning a global deployment of Veeva Vault CRM. Together, these developments highlight Veeva’s push to embed agentic AI across clinical, safety, quality, and commercial workflows, reinforcing its role as an end-to-end software partner for life sciences...

Veeva Systems launches new AI study design agent Veeva Systems (VEEV) has unveiled Veeva Study Builder Agent, an AI tool that configures its EDC and Data Quality System directly from a clinical study protocol, aiming to streamline and standardize trial setup. Recent AI product launches and new client wins have arrived alongside a sharp 71.27% 90 day share price return and an 8.97% 30 day share price return for Veeva Systems, while the 1 year total shareholder return is slightly down 2.59%,...

Doximity (DOCS), which calls itself the leading digital platform for U.S. medical professionals, has seen its stock fall steeply over the past year. Even after a rise over the past three months, the shares sit about 65% below their 52-week high. Management continued its repurchase program, allocating approximately $401 million over the latest twelve months. The test is whether it can keep that up through what it calls its AI investment year.

Veeva Systems (NYSE: VEEV) today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly from a study protocol. By reusing an organization's existing standards and leveraging the CDISC Unified Study Definitions Model (USDM), the agent ensures faster, more deterministic study builds.

The global Quality Management System (QMS) software market is projected to grow from USD 11.73 billion in 2026 to USD 20.43 billion by 2031, at an 11.7% CAGR. Growth is driven by cloud-based QMS platforms, AI-powered quality analytics, automated compliance workflows and integration with ERP, MES and PLM systems. SMEs are the fastest-growing customer segment, while document control and management holds the largest market share. North America leads the market, and Asia Pacific is the fastest-growi

Veeva Systems (NYSE: VEEV) today announced a new top 20 biopharma commitment, adding to recent selections by Amgen, Biogen, Eli Lilly and Company, and Regeneron. With more than 190 live customers and global commitments from 14 of the top 20 biopharmas, Vault CRM is the next generation of CRM, delivering new agentic and core capabilities to increase field productivity and effectiveness.

The global eClinical solutions market is projected to grow from USD 13.18 billion in 2025 to USD 25.22 billion by 2030, registering a 13.9% CAGR. Growth is driven by rising clinical trial costs, regulatory requirements, R&D investment, government funding, data standardization and adoption of innovative clinical research software. Data collection led the market in 2024, while pharmaceutical and biopharmaceutical companies were the largest end users. North America dominated due to advanced healthc

The global pharmacovigilance software market is projected to grow from USD 4.5 billion in 2026 to USD 12.7 billion by 2036, at a 10.9% CAGR. Growth is driven by stricter drug safety regulations, expanding clinical trials, rising adverse event data, and adoption of AI, automation, NLP and cloud platforms. North America leads the market, while Asia-Pacific will grow fastest. Key players include Oracle, IQVIA, ArisGlobal, Parexel, ICON, Veeva Systems and RxLogix.Dublin, Sept. 23, 2026 (GLOBE NEWSWI

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.

Veeva Systems (NYSE: VEEV) today announced Veeva Falcon Router, an industry-specific agent to identify and route potential safety adverse event reports, product quality complaints, and medical inquiries to the correct teams with speed and consistency.